Other
Hospitalized Patients
0
Pipeline Programs↗
3
Active Trials↗
6
Companies Involved↗
Hospitalized Patients is an early-stage landscape with 0 programs across 6 companies. The most active players are Pfizer, Lustre Pharmaceutical Lab Co., Ltd, Roche.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
43
clinical trials
Completed20 · 47%
Unknown status12 · 28%
Terminated5 · 12%
Recruiting2 · 5%
Withdrawn2 · 5%
Not yet recruiting1 · 2%
Other1 · 2%
Clinical Trials
Trial Activity
43 trials
Intravenous Alpha-1 Antitrypsin for Hospitalized Patients With COPD Exacerbations (AECOPD Study)
Not yet recruiting·FFondazione IRCCS Policlinico San Matteo di Pavia·Phase 2·NCT07125664·36 enrolled
Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19
Completed·IInstituto de Investigación Sanitaria de la Fundación Jiménez Díaz·Phase 4·NCT04392531·111 enrolled
Outcomes of Once-Daily ICS/LABA/LAMA + PRN Respiratory Therapy Treatments in Hospitalized Patients With COPD Exacerbations
Completed·—·Phase 4·NCT05292053·80 enrolled
Efficacy of Topiramate for Hospitalized Patients With Alcoholism
Completed·—·Phase 2/3·NCT01145677·90 enrolled
Prandial Insulin Dosing in Hospitalized Patients
Completed·—·Phase 4·NCT01101867·126 enrolled
Comparison of Apidra to Regular Insulin in Hospitalized Patients
Completed·—·N/A·NCT00528918·300 enrolled
The Effect of When Medication is Taken on Nutritional Status in Hospitalized Patients Older Than 65 Years
Completed·—·N/A·NCT02894827·30 enrolled
Nutrition Supplementation in Hospitalized Patients
Completed·LLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's·Phase 2·NCT02632630·100 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)